Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).

被引：1
|
作者：
Krantz, Benjamin A.
Tsui, Dana
Lowery, Maeve Aine
Capanu, Marinela
Yu, Kenneth H.
Kelsen, David Paul
Gedvilaite, Erika
Zhang, Liguo
Selcuklu, S. Duygu
You, Daoqi
Pernicka, Jennifer S. Golia
Do, Richard K. G.
Iacobuzio-Donahue, Christine A.
O'Reilly, Eileen Mary
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Trinity Coll Dublin, Dublin, Ireland
[3] Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.316
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
316
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Hereditary pancreatitis (HP) and the risk of pancreatic ductal adenocarcinoma (PDAC)
    Howes, N
    Lerch, MM
    Charnley, R
    Mössner, J
    Endres, S
    Deviere, J
    Verreman, V
    Lucidi, V
    Ohla, A
    Ihse, I
    Imrie, C
    Steenbergan, W
    Poll, A
    Greenhalf, W
    Ellis, I
    Mountford, R
    Whitcomb, DC
    Neoptolemos, JP
    GUT, 2002, 50 : A43 - A43
  • [32] Neuroplastic Changes in a Mouse Model of Pancreatic Ductal Adenocarcinoma (PDAC)
    Stopczynski, Rachelle E.
    DePinho, Ronald A.
    Ying, Haoqiang
    Schwartz, Erica S.
    Albers, Kathryn M.
    Davis, Brian M.
    Bielefeldt, Klaus
    GASTROENTEROLOGY, 2010, 138 (05) : S62 - S62
  • [33] Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
    Pervin, Jannat
    Asad, Mohammad
    Cao, Shaolong
    Jang, Gun Ho
    Feizi, Nikta
    Haibe-Kains, Benjamin
    Karasinska, Joanna M.
    O'Kane, Grainne M.
    Gallinger, Steven
    Schaeffer, David F.
    Renouf, Daniel J.
    Zogopoulos, George
    Bathe, Oliver F.
    FRONTIERS IN GENETICS, 2023, 14
  • [34] Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC
    Oba, A.
    Bao, Q. R.
    Barnett, C. C.
    AI-Musawi, M. H.
    Croce, C.
    Schulick, R. D.
    Del Chiaro, M.
    SCANDINAVIAN JOURNAL OF SURGERY, 2020, 109 (01) : 18 - 28
  • [35] Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
    Jacobs, Michelle F.
    Stoffel, Elena M.
    FAMILIAL CANCER, 2024, 23 (03) : 221 - 232
  • [36] Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
    Koustoulidou, S.
    Knight, J. C.
    Kersemans, V.
    O'Neill, E.
    Cornelissen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S230 - S230
  • [37] Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
    Chen, Hao
    Yang, Gang
    Xiao, Jianchun
    Zheng, Lianfang
    You, Lei
    Zhang, Taiping
    CANCER LETTERS, 2020, 490 : 12 - 19
  • [38] Exploring therapeutic strategies against pancreatic ductal adenocarcinoma (PDAC).
    Liaki, Vasiliki
    CANCER RESEARCH, 2021, 81 (22) : 58 - 59
  • [39] Peptides as a targeting strategy to eradicate Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Rossa, Andrea
    Bachmann, Magdalena
    Corbo, Vincenzo
    Mattarei, Andrea
    Ruzza, Paolo
    Biasutto, Lucia
    Szabo, Ildiko
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (08): : 10 - 10
  • [40] Elucidating role of bacteria during pancreatic ductal adenocarcinoma (PDAC).
    Chandra, Vidhi
    Le Roux, Olivereen
    Riquelme, Erick
    Zhang, Yu
    Maitra, Anirban
    White, James. R.
    McAllister, Florencia
    CANCER RESEARCH, 2020, 80 (08) : 27 - 27
12345